GETI-B:STO
Getinge publ AB
250,00 SEK
arrow_downward
-0,24%(-0,60) 1D
7 ოქტ, 17:29:49 GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GETI-B...
Open
250,40 SEK
High
252,30 SEK
Low
248,40 SEK
Mkt. cap
63,00 მლრდ.
Avg. vol.
578,49 ათ.
Volume
748,53 ათ.
Dividend
1,90%
Quarterly dividend
1,19 SEK
Ex-dividend date
22 აპრ. 2026
P/E ratio
25,46
52-wk high
252,30 SEK
52-wk low
175,90 SEK
EPS
9,82 SEK
Shares outstanding
254,15 მლნ.
No. of employees
12 ათ.
Open
250,40 SEK
High
252,30 SEK
Low
248,40 SEK
Mkt. cap
63,00 მლრდ.
Avg. vol.
578,49 ათ.
Volume
748,53 ათ.
Dividend
1,90%
Quarterly dividend
1,19 SEK
Ex-dividend date
22 აპრ. 2026
P/E ratio
25,46
52-wk high
252,30 SEK
52-wk low
175,90 SEK
EPS
9,82 SEK
Shares outstanding
254,15 მლნ.
No. of employees
12 ათ.
News stories
From web sources and news partners
TipRanks
·
7 საათის წინ
Getinge’s Life Science President Eric Honroth to Step Down
www.marketscreener.com
·
7 საათის წინ
Getinge's Business Area Head Eric Honroth Leaves the Company
TipRanks
·
12 საათის წინ
Getinge Schedules Q3 2026 Report Release and Investor Call
Profile
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
About Getinge publ AB